ATRC

Handel nachbörslich: 35.47

Atricure Inc (ATRC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Atricure Inc Stock (ATRC) Company Profile

Atricure Inc

Healthcare (1182)

513-755-4100

7555 INNOVATION WAY, MASON, OH

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ATRC's Discussions on Twitter

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-08-05	Herabstufung	Oppenheimer	Outperform → Perform
2020-12-18	Bestätigt	Needham	Buy
2020-11-06	Bestätigt	Needham	Buy
2020-04-07	Eingeleitet	Oppenheimer	Outperform
2020-02-06	Eingeleitet	BTIG Research	Buy
2020-01-24	Bestätigt	Needham	Buy
2019-08-13	Herabstufung	Northland Capital	Outperform → Market Perform
2019-04-12	Eingeleitet	JP Morgan	Overweight
2018-10-04	Bestätigt	Needham	Buy
2018-08-02	Bestätigt	Needham	Buy
2018-08-02	Bestätigt	Stifel	Buy
2018-06-18	Bestätigt	Needham	Buy
2018-04-27	Bestätigt	Needham	Buy
2018-01-16	Bestätigt	Needham	Buy
2017-11-02	Bestätigt	Needham	Buy
2017-07-28	Bestätigt	Needham	Buy
2017-05-30	Fortgesetzt	Piper Jaffray	Overweight
2016-06-30	Fortgesetzt	JMP Securities	Mkt Outperform
2015-10-28	Bestätigt	Needham	Buy
2015-10-06	Bestätigt	Canaccord Genuity	Buy
2015-10-06	Bestätigt	Needham	Buy

Alle ansehen

Atricure Inc Aktie (ATRC) Neueste Nachrichten

Finanzdaten der Atricure Inc-Aktie (ATRC)

Atricure Inc (ATRC)

Atricure Inc Stock (ATRC) Company Profile

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Atricure Inc Aktie (ATRC) Neueste Nachrichten

Emerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday - MSN

US$42.67That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results - Simply Wall St

AtriCure, Inc. (NASDAQ:ATRC) Q3 2024 Earnings Call Transcript - Insider Monkey

AtriCure Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? - Simply Wall St

Earnings call: AtriCure reports robust growth, raises full-year guidance By Investing.com - Investing.com Nigeria

Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation By Investing.com - Investing.com South Africa

AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com

AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN

AtriCure price target raised to $36 from $32 at Oppenheimer - MSN

AtriCure (NASDAQ:ATRC) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation - Investing.com India

AtriCure (NASDAQ:ATRC) Shares Gap Up Following Strong Earnings - MarketBeat

AtriCure (NASDAQ:ATRC) Given New $40.00 Price Target at Needham & Company LLC - MarketBeat

AtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 8.4% in October - MarketBeat

AtriCure Reports Strong Growth in Q3 2024 Earnings - TipRanks

AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Yahoo Finance

AtriCure: Q3 Earnings Snapshot - The Washington Post

AtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings Guidance - MarketBeat

AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

AtriCure Inc (ATRC) Q3 2024 Earnings: Revenue Surpasses Estimates at $115.9 Million, Net Loss Per Share at $0.17 - GuruFocus.com

AtriCure Reports Third Quarter 2024 Financial Results - StockTitan

Assenagon Asset Management S.A. Purchases 138,046 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

AtriCure to Participate in the UBS Global Healthcare Conference - StockTitan

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

AtriCure (ATRC) Scheduled to Post Earnings on Tuesday - MarketBeat

Cardiac Ablation Technology Market Analysis By Top Keyplayers - openPR

(ATRC) Long Term Investment Analysis - Stock Traders Daily

AtriCure Inc (ATRC) Trading Down 2.91% on Oct 17 - GuruFocus.com

SG Americas Securities LLC Buys New Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device - Yahoo Finance

AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management - BioSpace

AtriCure launches new CryoSphere Max cryoablation probe - Mass Device

Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago - Yahoo Finance

AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe - Yahoo Finance

Atrial Fibrillation Market Rapid Growth, Challenges, - openPR

Atrial Appendage Occluder Market Set to Soar to USD 8,193.0 Million by 2033 at a 23.6% of CAGR - Future Market Insights

Is Atricure Inc (ATRC) a threat to investors? - US Post News

Transcatheter Embolization and Occlusion Devices Market Analysis To 2031 | Inc, AtriCure, Stryker Corporation, Merit Medical System, Pfizer, Inc, Edwards – Times-BD24 - Times-BD24

Where are the Opportunities in (ATRC) - Stock Traders Daily

There is no doubt that Atricure Inc (ATRC) ticks all the boxes. - SETE News

Market Insight: Atricure Inc (ATRC)’s Notable Drop, Closing at 27.07 - The Dwinnex

Atrial Fibrillation Market Growth Analysis with Investment Opportunities For 2024-2033 - EIN News

AtriCure to Announce Third Quarter 2024 Financial Results - StockTitan

AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Millennium Management LLC Has $21.69 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

AtriCure wins CE mark for EnCompass clamp device - Mass Device

Finanzdaten der Atricure Inc-Aktie (ATRC)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie ATRC